Evolent Health (Evolent Health) Days Sales Outstanding : 69.00 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Evolent Health Days Sales Outstanding?

Evolent Health's average Accounts Receivable for the three months ended in Dec. 2023 was $420 Mil. Evolent Health's Revenue for the three months ended in Dec. 2023 was $556 Mil. Hence, Evolent Health's Days Sales Outstanding for the three months ended in Dec. 2023 was 69.00.

The historical rank and industry rank for Evolent Health's Days Sales Outstanding or its related term are showing as below:

EVH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 37.59 Med: 43.81 Max: 76.79
Current: 63.33

During the past 11 years, Evolent Health's highest Days Sales Outstanding was 76.79. The lowest was 37.59. And the median was 43.81.

EVH's Days Sales Outstanding is ranked worse than
68.59% of 640 companies
in the Healthcare Providers & Services industry
Industry Median: 46.205 vs EVH: 63.33

Evolent Health's Days Sales Outstanding increased from Dec. 2022 (52.77) to Dec. 2023 (69.00).

Evolent Health Days Sales Outstanding Historical Data

The historical data trend for Evolent Health's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolent Health Days Sales Outstanding Chart

Evolent Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

41.40

39.42

51.19

52.01

65.18

Evolent Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															52.77	55.20	59.13	66.03	69.00

Competitive Comparison of Evolent Health's Days Sales Outstanding

For the Health Information Services subindustry, Evolent Health's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evolent Health's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Evolent Health's Days Sales Outstanding falls into.

Evolent Health Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Evolent Health's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (254.684	+	446.749)	/	2 )	/	1963.896	*	365
=	350.7165					/	1963.896	*	365
=	65.18

Evolent Health's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (394.232	+	446.749)	/	2 )	/	556.055	*	365 / 4
=	420.4905					/	556.055	*	365 / 4
=	69.00

Evolent Health (NYSE:EVH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Evolent Health Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Evolent Health's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolent Health (Evolent Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Evolent Health Inc (NYSE:EVH) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

9EH:Germany

Address

800 N. Glebe Road, Suite 500, Arlington, VA, USA, 22203

Website

https://www.evolenthealth.com

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's two reportable segments: EHS and Clinical Solutions. The Company's EHS segment provides an integrated administrative and clinical platform for health plan administration and value-based business infrastructure and clinical Solutions segment addresses a broad spectrum of clinical needs, with tailored solutions for specialty care management in oncology and cardiology and increasingly the musculoskeletal markets and holistic total cost of care improvement. It generates a majority of its revenue from Clinical Solutions segment.

Executives

Seth Blackley	officer: President	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Daniel Joseph Mccarthy	officer: PRESIDENT	800 N GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Emily Ann Rafferty	officer: Chief Operating Officer	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Toyin Ajayi	director	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Cheryl Scott	director	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Mary Bridget Duffy	director	C/O VOCERA COMMUNICATIONS, INC., 525 RACE STREET, SAN JOSE CA 95126
Diane Holder	director	800 GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Richard M Jelinek	director	40 W 47TH STREET, FLOOR 33, NEW YORK NY 10035
Frank J Williams	director, officer: Chief Executive Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
John Paul Johnson	officer: Chief Financial Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Jonathan Weinberg	officer: General Counsel	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Steve Tutewohl	officer: Chief Operating Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Tunde Sotunde	director	800 N. GLEBE RD, SUITE 500, ARLINGTON VA 22203
Kim Keck	director	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
Craig A. Barbarosh	director	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305